Natus Medical, Inc. (BABY) Tops Q1 EPS by 3c; Boosts FY14 EPS Outlook

Natus Medical, Inc. (NASDAQ: BABY) reported Q1 EPS of $0.26, $0.03 better than the analyst estimate of $0.23. Revenue for the quarter came in at $85.6 million versus the consensus estimate of $84.7 million.

Natus Medical, Inc. sees FY2014 EPS of $1.18-$1.21, versus prior guidance of $1.14-$1.18. The Street is at FY14 EPS of $1.19.

Natus Medical, Inc. sees Q2 2014 EPS of $0.24-$0.27. The Street consensus is $0.26.

For earnings history and earnings-related data on Natus Medical, Inc. (BABY) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c
• Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c